These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 1982341)
21. Cardiovascular response to 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) in the rat: site of action and pharmacological analysis. Fozard JR; Mir AK; Middlemiss DN J Cardiovasc Pharmacol; 1987 Mar; 9(3):328-47. PubMed ID: 2437400 [TBL] [Abstract][Full Text] [Related]
22. The behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in mice. Yamada J; Sugimoto Y; Horisaka K Eur J Pharmacol; 1988 Sep; 154(3):299-304. PubMed ID: 2976671 [TBL] [Abstract][Full Text] [Related]
24. Destruction of the nucleus raphe obscurus and potentiation of serotonin-mediated behaviors following administration of the neurotoxin 3-acetylpyridine. Wieland S; Kreider MS; McGonigle P; Lucki I Brain Res; 1990 Jun; 520(1-2):291-302. PubMed ID: 1698505 [TBL] [Abstract][Full Text] [Related]
25. Contractile effects of 8-hydroxy-2-(di-n-propylamino)tetralin and flesinoxan in human isolated basilar artery. Parsons AA; Motevalian M; Whalley ET Eur J Pharmacol; 1991 Sep; 202(1):17-23. PubMed ID: 1664803 [TBL] [Abstract][Full Text] [Related]
26. Antagonism studies with BMY-7378 and NAN-190: effects on 8-hydroxy-2-(di-n-propylamino)tetralin-induced increases in punished responding of pigeons. Ahlers ST; Weissman BA; Barrett JE J Pharmacol Exp Ther; 1992 Feb; 260(2):474-81. PubMed ID: 1531359 [TBL] [Abstract][Full Text] [Related]
27. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor. Tricklebank MD; Neill J; Kidd EJ; Fozard JR Eur J Pharmacol; 1987 Jan; 133(1):47-56. PubMed ID: 2881789 [TBL] [Abstract][Full Text] [Related]
28. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors. Goodwin GM; Green AR Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582 [TBL] [Abstract][Full Text] [Related]
29. Abnormal ACTH and prolactin responses to fenfluramine in rats exposed to single and multiple doses of MDMA. Poland RE; Lutchmansingh P; McCracken JT; Zhao JP; Brammer GL; Grob CS; Boone KB; Pechnick RN Psychopharmacology (Berl); 1997 Jun; 131(4):411-9. PubMed ID: 9226745 [TBL] [Abstract][Full Text] [Related]
30. Pharmacological characterization of 8-OH-DPAT-induced inhibition of rat hippocampal 5-HT release in vivo as measured by microdialysis. Sharp T; Bramwell SR; Hjorth S; Grahame-Smith DG Br J Pharmacol; 1989 Nov; 98(3):989-97. PubMed ID: 2574066 [TBL] [Abstract][Full Text] [Related]
31. Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine. Nash JF; Meltzer HY; Gudelsky GA J Pharmacol Exp Ther; 1988 Jun; 245(3):873-9. PubMed ID: 2898523 [TBL] [Abstract][Full Text] [Related]
32. Conditioned reinforcing effects of 8-hydroxy-2-(di-N-propylamino) tetralin: involvement of 5-hydroxytryptamine 1A and D1 dopamine receptors. Shippenberg TS Neurosci Lett; 1991 Jan; 121(1-2):136-8. PubMed ID: 1826942 [TBL] [Abstract][Full Text] [Related]
33. Low doses of the putative serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) elicit feeding in the rat. Dourish CT; Hutson PH; Curzon G Psychopharmacology (Berl); 1985; 86(1-2):197-204. PubMed ID: 3161115 [TBL] [Abstract][Full Text] [Related]
34. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats. Lejeune F; Newman-Tancredi A; Audinot V; Millan MJ J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310 [TBL] [Abstract][Full Text] [Related]
35. 3,4-Methylenedioxymethamphetamine- and 8-hydroxy-2-di-n-propylamino-tetralin-induced hypothermia: role and location of 5-hydroxytryptamine 1A receptors. Rusyniak DE; Zaretskaia MV; Zaretsky DV; DiMicco JA J Pharmacol Exp Ther; 2007 Nov; 323(2):477-87. PubMed ID: 17702902 [TBL] [Abstract][Full Text] [Related]
36. Single exposure to a serotonin 1A receptor agonist, (+)8-hydroxy-2-(di-n-propylamino)-tetralin, produces a prolonged heterologous desensitization of serotonin 2A receptors in neuroendocrine neurons in vivo. Carrasco GA; Van de Kar LD; Jia C; Xu H; Chen Z; Chadda R; Garcia F; Muma NA; Battaglia G J Pharmacol Exp Ther; 2007 Mar; 320(3):1078-86. PubMed ID: 17159160 [TBL] [Abstract][Full Text] [Related]
37. [Behavioural effects of 8-OH-DPAT, a 5-HT1A agonist in rats and effects on the behaviour of antimanic drugs]. Uchitomi Y; Yamawaki S Yakubutsu Seishin Kodo; 1987 Sep; 7(3):383-92. PubMed ID: 2894736 [TBL] [Abstract][Full Text] [Related]
38. Behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in monkeys. Mizuta E; Yamaguchi M; Kuno S Eur J Pharmacol; 1990 Mar; 178(1):125-7. PubMed ID: 2139614 [TBL] [Abstract][Full Text] [Related]
39. Cardiovascular and adrenaline-releasing effects of the 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin in streptozotocin diabetic rats. Chaouloff F; Blanc J; Baudrie V; Laude D; Elghozi JL Life Sci; 1991; 48(26):2543-52. PubMed ID: 1828521 [TBL] [Abstract][Full Text] [Related]
40. Effects of 8-hydroxy-2-(di-n-propylamino)tetralin, a selective agonist of 5-HT1A receptors, on the cough reflex in rats. Kamei J; Mori T; Igarashi H; Kasuya Y Eur J Pharmacol; 1991 Oct; 203(2):253-8. PubMed ID: 1839282 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]